Atropine eye drops to control myopia progression

15 August 2019
Volume 20, Issue 3

This paper critically reviews scientific studies investigating the efficacy of atropine at regressing myopia progression in children.

How effective are atropine eye drops at reducing myopia progression in children? provides a critical appraisal of the literature with regard to clinical use of atropine for myopia control. Low-dose atropine is an effective pharmacological myopia control strategy. Although not yet available commercially in the UK, clinical trials are ongoing at present and the drug could be adopted in the near future for myopia control.

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

A framework for delivering eye care to children in special schools aims to help those who often seek treatment the least, writes Anna Scott.

Adrian O’Dowd asks if the growing use of topography in community optometry will lead to wavefront analysis gaining traction as a complementary tool.

Here we summarise three research papers from a recent issue of Optometry in Practice.